0
Vaxart, Inc. Banner Image

Vaxart, Inc. has reached its limit for free report views

Work for Vaxart, Inc.? Upgrade Your Profile and unlock all your annual reports.

Vaxart, Inc.

  • Ticker VXRT
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Vaxart, Inc. Logo Image
  • 11-50 Employees
  • Based in South San Francisco, California
Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using convenient room temperature-stable tablets that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart has demonstrated that its proprietary tabletMore vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications. Its development programs currently include tablet vaccines designed to protect against coronavirus, norovirus, seasonal influenza and respiratory syncytial virus (RSV), as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart’s first immuno-oncology indication. Vaxart has filed broad domestic and international patents covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.
Vaxart, Inc.

Most Recent Annual Report

Vaxart, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Vaxart, Inc. has reached its limit for free report views.

Older/Archived Annual Reports